« Return to News | CROs/Service Providers

UBC Partners with Clearstate to Serve Asia-Pacific

Friday, April 16, 2010 09:07 AM

United BioSource Corporation (UBC) partnered with Singapore-based Clearstate, a market intelligence firm focused on the healthcare and pharmaceutical industry. Through this partnership, UBC will offer market access, pricing and reimbursement strategies for drug and device manufacturers in the Asia-Pacific region.

“We are extremely pleased to partner with Clearstate to offer comprehensive market access strategies throughout the Asia-Pacific region,” said Lisbet Coulton, UBC’s director of international pricing and reimbursement.  “As life science companies expand their operations throughout the Asia-Pacific region, UBC and Clearstate are ideally positioned to support their products. Our clients have been delighted with the insight and expertise provided by Clearstate and we believe our partnership offers significant value for companies seeking effective market access solutions in this region.”

UBC opened its first office in Asia-Pacific in February. This Tokyo office will have a staff of 12 by the end of the year, according to UBC CEO Ethan Leder. Leder told CenterWatch earlier this year that the Asia-Pacific region has grown increasingly important to UBC as both regional and worldwide clients have requested increased services there.

“We’ve been doing work for Japanese companies for a long time, and they’re some of our best customers—in both the rest of world and in Japan,” Leder said. “We felt it was important—not just with those Japanese companies but with some of the other ex-Japan companies that are developing drugs and marketing drugs in-country—to be on the ground.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.